Regulation of the Promotion of Prescription Drugs (DDMAC Update)
March 16, 2011
Bryant Godfrey, regulatory counsel, Division of Drug Marketing, Advertising and Communications, Food and Drug Administration, provided an update on what areas the agency is currently focusing on and how they may impact the advertising industry.
Access to this content item is restricted to:
- ANA Corporate Marketer Members
Please login below or create an account.
You may already be a member. Find out if your company is already an ANA member.